Comments (10) Eli Lillys (LLY) obesity therapy, tirzepatide, can lead to greater weight loss but with a greater loss of lean body mass compared to Novo Nordisks (NVO) rival therapy, semaglutide, according to a new study based on real-world data
Mammalian spermatozoa are coated by a membrane rich in polyunsaturated fatty acids
In this trial, 17,604 patients were assigned to receive a once-weekly injection of 2.4 mg of semaglutide or placebo (mean follow-up of 39.8 months)
most of the fatalities following administration of an EDTA drug have involved medication errors in which edetate disodium was administered instead of edetate calcium disodium
Moderate cardio, perhaps 20-30 minutes three to four times weekly, supports caloric deficit goals without becoming catabolic
Telomere length shortening leads to a reduction in mtDNA copy number